科力尔(002892) - 2022 Q3 - 季度财报

Key Financial Data This section provides an overview of the company's key financial performance and position for the reporting period and year-to-date Key Accounting Data and Financial Indicators The company experienced a significant decline in Q3 and year-to-date operating performance, with revenue and net profit falling, yet operating cash flow substantially improved Key Financial Indicators for Q3 2022 and Year-to-Date | Indicator | Current Period (Q3) | YoY Change (Current Period) | Year-to-Date | YoY Change (Year-to-Date) | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue (CNY) | 263,617,832.39 | -33.58% | 890,761,951.01 | -15.67% | | Net Profit Attributable to Shareholders (CNY) | -10,539,827.97 | -127.72% | 53,869,586.46 | -34.18% | | Net Profit Attributable to Shareholders (Excluding Non-Recurring Items) (CNY) | 12,600,924.75 | -65.17% | 57,663,361.80 | -27.15% | | Net Cash Flow from Operating Activities (CNY) | — | — | 127,239,576.99 | 957.39% | | Basic Earnings Per Share (CNY/share) | -0.0335 | -127.75% | 0.1710 | -34.18% | | Total Assets (CNY) | 1,637,439,473.37 | 3.43% (vs. end of prior year) | 1,637,439,473.37 | 3.43% (vs. end of prior year) | | Total Equity Attributable to Shareholders (CNY) | 1,247,848,140.56 | -0.46% (vs. end of prior year) | 1,247,848,140.56 | -0.46% (vs. end of prior year) | Non-Recurring Gains and Losses Items and Amounts Non-recurring losses totaled -CNY 23.14 million for the quarter and -CNY 3.79 million year-to-date, primarily due to fair value changes in financial instruments and charitable donations Details of Non-Recurring Gains and Losses (Year-to-Date) | Item | Amount for Current Period (CNY) | Amount Year-to-Date (CNY) | | :--- | :--- | :--- | | Gains/Losses on Disposal of Non-Current Assets | 97,087.98 | 186,317.32 | | Government Grants | 1,242,460.42 | 2,839,985.95 | | Fair Value Changes of Transactional Financial Instruments, etc | -25,160,554.92 | -3,195,683.87 | | Other Non-Operating Income and Expenses | -3,359,769.65 | -4,301,770.42 | | Total | -23,140,752.72 | -3,793,775.34 | Analysis of Changes in Key Financial Data and Indicators Significant financial changes include an 859.72% surge in intangible assets from land acquisition, a 999.62% drop in financial expenses due to exchange gains, and a 957.39% increase in operating cash flow from improved collections - Intangible assets increased by 859.72%, primarily due to the acquisition of land in Huizhou Industrial Park, adding CNY 80.8775 million[12] - Financial expenses decreased by 999.62%, mainly due to increased exchange gains from RMB depreciation[13] - Net cash flow from operating activities increased by 957.39%, primarily due to the company's intensified efforts in accounts receivable collection, accelerating cash recovery[14] - Total profit and net profit decreased by 38.49% and 38.24% respectively, mainly due to a decline in the company's main business revenue influenced by market conditions[13][14] - Asset impairment losses increased by 179.06%, primarily due to inventory buildup from adjusted customer orders impacted by the Russia-Ukraine conflict and the pandemic, leading to increased impairment provisions[13] Shareholder Information This section details the company's shareholder structure, including the total number of shareholders and the holdings of major investors Shareholding Status of Shareholders As of the reporting period, the company had 27,029 common shareholders, with actual controllers Nie Pengju and Nie Baosheng holding over 51% of shares, indicating a concentrated equity structure - Total common shareholders at the end of the reporting period were 27,029[17] - The company's actual controllers, Nie Pengju and Nie Baosheng (father-son), collectively hold approximately 51.69% of the shares[17] Shareholding Status of Top Five Shareholders | Shareholder Name | Shareholder Type | Shareholding Percentage | Number of Shares Held | | :--- | :--- | :--- | :--- | | Nie Pengju | Domestic Natural Person | 25.94% | 81,710,244 | | Nie Baosheng | Domestic Natural Person | 25.75% | 81,102,448 | | Tang Yi | Domestic Natural Person | 2.26% | 7,126,980 | | Li Wei | Domestic Natural Person | 1.07% | 3,371,060 | | Yimei Biotechnology (Haimen) Co., Ltd. | Domestic Non-State-Owned Legal Entity | 0.71% | 2,248,620 | Other Significant Matters This section confirms the absence of any other material events or disclosures during the reporting period Other Significant Matters The company had no other significant matters requiring disclosure during the reporting period - The company had no other significant matters in this reporting period[20] Quarterly Financial Statements This section presents the company's unaudited consolidated financial statements for the third quarter and year-to-date period Financial Statements This section presents the consolidated balance sheet as of September 30, 2022, and the consolidated income and cash flow statements for the year-to-date period, reflecting the company's financial performance Consolidated Balance Sheet As of September 30, 2022, total assets reached CNY 1.637 billion (up 3.43%), total liabilities were CNY 370 million, and equity attributable to owners was CNY 1.248 billion (down 0.46%), with intangible assets driving asset growth Key Items from Consolidated Balance Sheet (Unit: CNY) | Item | September 30, 2022 | January 1, 2022 | | :--- | :--- | :--- | | Total Assets | 1,637,439,473.37 | 1,583,174,748.17 | | Total Liabilities | 370,011,419.12 | 329,518,825.91 | | Total Equity Attributable to Owners of the Parent Company | 1,247,848,140.56 | 1,253,655,922.26 | | Total Liabilities and Equity | 1,637,439,473.37 | 1,583,174,748.17 | Consolidated Income Statement (Year-to-Date) For the first three quarters of 2022, total operating revenue was CNY 891 million (down 15.67%), and net profit attributable to the parent was CNY 53.87 million (down 34.18%), with exchange gains significantly supporting profit Key Items from Consolidated Income Statement (Unit: CNY) | Item | Current Period Amount (2022 Q1-Q3) | Prior Period Amount (2021 Q1-Q3) | | :--- | :--- | :--- | | I. Total Operating Revenue | 890,761,951.01 | 1,056,262,126.46 | | II. Total Operating Costs | 826,953,735.06 | 960,414,980.56 | | Including: Financial Expenses | -19,953,967.45 | 2,218,050.69 | | III. Operating Profit | 57,953,892.28 | 90,451,093.58 | | IV. Total Profit | 55,634,470.37 | 90,447,638.88 | | V. Net Profit | 50,549,500.15 | 81,848,185.65 | | Net Profit Attributable to Shareholders of the Parent Company | 53,869,586.46 | 81,848,185.65 | | VIII. Basic Earnings Per Share | 0.1710 | 0.2598 | Consolidated Cash Flow Statement (Year-to-Date) For the first three quarters of 2022, net cash flow from operating activities significantly turned positive to CNY 127 million, while investing activities had a net outflow of CNY 53.59 million, and financing activities saw a reduced net inflow of CNY 31.13 million Key Items from Consolidated Cash Flow Statement (Unit: CNY) | Item | Current Period Amount (2022 Q1-Q3) | Prior Period Amount (2021 Q1-Q3) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 127,239,576.99 | -14,840,379.67 | | Net Cash Flow from Investing Activities | -53,591,560.59 | -206,384,715.51 | | Net Cash Flow from Financing Activities | 31,130,514.99 | 403,524,014.14 | | Net Increase in Cash and Cash Equivalents | 108,817,018.26 | 181,899,769.31 | | Cash and Cash Equivalents at Period-End | 552,466,610.11 | 359,566,585.75 | Audit Report The company's third-quarter 2022 report remains unaudited - The company's third-quarter report is unaudited[37]